Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O'Mareen Spence

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Pharmacoepidemiology and Drug Safety|June 20, 2020
Spillover effects of state medicaid antipsychotic prior authorization policies in US commercially insured youthO'Mareen Spence, Gloria Reeves, Susan dosReis
Pharmacoepidemiology and Drug Safety|September 16, 2021
Evaluating the association between antidepressant dose trajectories and treatment augmentation in pediatric depressionO'Mareen Spence, Gloria Reeves, Susan dosReis
The New England Journal of Medicine|January 19, 2018
Noninferiority TrialsPeter Doshi, O'Mareen Spence, John H Powers
Trials|May 5, 2018
Patient consent to publication and data sharing in industry and NIH-funded clinical trialsO'Mareen Spence, Richie Onwuchekwa Uba, Seongbin Shin, et al.
JAMA Internal Medicine|March 5, 2019
Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017Peter Doshi, O'Mareen Spence, Aida Kuzucan, et al.
Frontiers in Psychiatry|May 17, 2021
Cardiovascular Risk of Concomitant Use of Atypical Antipsychotics and Stimulants Among Commercially Insured Youth in the United StatesChengchen Zhang, O'Mareen Spence, Gloria Reeves, et al.
Dermatology and Therapy|February 28, 2024
Herpes Zoster Recurrence: A Narrative Review of the LiteratureRaunak Parikh, O'Mareen Spence, Nikolaos Giannelos, et al.
JAMA Pediatrics|November 2, 2020
Characteristics of Youths Treated With Psychotropic Polypharmacy in the United States, 1999 to 2015Chengchen Zhang, O'Mareen Spence, Gloria Reeves, et al.
Clinical Pharmacology and Therapeutics|April 3, 2021
Evaluation of Switch-to-Brand Rates as a Potential Signal for Therapeutic Equivalency of Generic Antidepressants: A Real-World Retrospective Cohort StudyShamir Kalaria, O'Mareen Spence, Kyungwan Hong, et al.
Journal of Child and Adolescent Psychopharmacology|March 19, 2019
Psychiatric Services Preceding Initiation of Antipsychotic Medication Among Youth in Foster CareO'Mareen Spence, Wendy Camelo Castillo, Gloria Reeves, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pharmacoepidemiology and Drug Safety|June 20, 2020
Spillover effects of state medicaid antipsychotic prior authorization policies in US commercially insured youthO'Mareen Spence, Gloria Reeves, Susan dosReis
Pharmacoepidemiology and Drug Safety|September 16, 2021
Evaluating the association between antidepressant dose trajectories and treatment augmentation in pediatric depressionO'Mareen Spence, Gloria Reeves, Susan dosReis
The New England Journal of Medicine|January 19, 2018
Noninferiority TrialsPeter Doshi, O'Mareen Spence, John H Powers
Trials|May 5, 2018
Patient consent to publication and data sharing in industry and NIH-funded clinical trialsO'Mareen Spence, Richie Onwuchekwa Uba, Seongbin Shin, et al.
JAMA Internal Medicine|March 5, 2019
Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017Peter Doshi, O'Mareen Spence, Aida Kuzucan, et al.
Frontiers in Psychiatry|May 17, 2021
Cardiovascular Risk of Concomitant Use of Atypical Antipsychotics and Stimulants Among Commercially Insured Youth in the United StatesChengchen Zhang, O'Mareen Spence, Gloria Reeves, et al.
Dermatology and Therapy|February 28, 2024
Herpes Zoster Recurrence: A Narrative Review of the LiteratureRaunak Parikh, O'Mareen Spence, Nikolaos Giannelos, et al.
JAMA Pediatrics|November 2, 2020
Characteristics of Youths Treated With Psychotropic Polypharmacy in the United States, 1999 to 2015Chengchen Zhang, O'Mareen Spence, Gloria Reeves, et al.
Clinical Pharmacology and Therapeutics|April 3, 2021
Evaluation of Switch-to-Brand Rates as a Potential Signal for Therapeutic Equivalency of Generic Antidepressants: A Real-World Retrospective Cohort StudyShamir Kalaria, O'Mareen Spence, Kyungwan Hong, et al.
Journal of Child and Adolescent Psychopharmacology|March 19, 2019
Psychiatric Services Preceding Initiation of Antipsychotic Medication Among Youth in Foster CareO'Mareen Spence, Wendy Camelo Castillo, Gloria Reeves, et al.
Pageof 2